Zevra Therapeutics Inc.
Biotechnology
Healthcare
ZVRA
47.81 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
6.44
52 week high
9.68
high
7.02
52 week low
4.26
previous Close
6.59
P/E ratio
market cap
458 M
div yield
0
net incoming
-33.23 M
-66.75 %
net profit margin
-899.19 %
-451.00 %
operating incoming
-27.31 M
-14.76 %
net change in cash
14.78 M
511.79 %
cash on hand
54.04 M
37.64 %
cost of revenue
2.30 M
-35.54 %
top